Elan Moves ELND005 into Phase III, Nixes Drug Delivery
DUBLIN, Ireland Elan Corp. plc has decided against spinning out its drug delivery arm, Elan Drug Technologies (EDT), into a separate business after concluding that "market conditions at this time are not conducive to an appropriate valuation." (BioWorld International)
To continue reading subscribe now to BioWorld Asia (formerly International)
Learn More about BioWorld Asia (formerly International)
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.